Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44. (Q36084344)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44. |
scientific article |
Statements
1 reference
Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44. (English)
1 reference
Hidehiro Tajima
1 reference
Tetsuo Ohta
1 reference
Hirohisa Kitagawa
1 reference
Koichi Okamoto
1 reference
Seisho Sakai
1 reference
Jun Kinoshita
1 reference
Isamu Makino
1 reference
Hiroyuki Furukawa
1 reference
Hironori Hayashi
1 reference
Keishi Nakamura
1 reference
Katsunobu Oyama
1 reference
Masafumi Inokuchi
1 reference
Hisatoshi Nakagawara
1 reference
Hideto Fujita
1 reference
Hiroyuki Takamura
1 reference
Itasu Ninomiya
1 reference
Sachio Fushida
1 reference
Takashi Tani
1 reference
Takashi Fujimura
1 reference
Seiko Kitamura
1 reference
Hiroko Ikeda
1 reference
Koichi Tsuneyama
1 reference
26 March 2012
1 reference
1 reference
1186-1190
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference